The university entered a purchase option agreement in 2025, but the buyer has since experienced #financial difficulty. A ...
Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results